Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Non-Current Deferred Tax Liability came in at $159.0 million in Q1 2026, down 19.29% year-on-year from $197.0 million in Q1 2025, and down 11.17% quarter-over-quarter from $179.0 million in Q4 2025.
Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Non-Current Deferred Tax Liability across 16 years of filings, most recently posting $159.0 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $159.0 million, down 19.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $159.0 million (down 19.29% YoY), and the FY2025 annual result was $179.0 million, down 8.67% from the prior year.
- Non-Current Deferred Tax Liability came in at $159.0 million for Q1 2026 at Iqvia Holdings, down from $179.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $976.0 million in Q4 2022 to a low of $128.0 million in Q3 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $216.0 million (2025), against an average of $352.9 million.
- Across the five-year window, Non-Current Deferred Tax Liability soared 138.05% in 2022 and tumbled 74.41% in 2024, its largest moves.
- Iqvia Holdings' Non-Current Deferred Tax Liability stood at $976.0 million in 2022, then decreased by 21.52% to $766.0 million in 2023, then sank by 74.41% to $196.0 million in 2024, then dropped by 8.67% to $179.0 million in 2025, then dropped by 11.17% to $159.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $159.0 million (Q1 2026), $179.0 million (Q4 2025), and $207.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.00 Mn |
| Mar 31, 2026 | 159.00 Mn |
| Dec 31, 2025 | 179.00 Mn |
| Dec 31, 2025 | 179.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Jun 30, 2025 | 216.00 Mn |
| Jun 30, 2025 | 216.00 Mn |
| Mar 31, 2025 | 197.00 Mn |
| Mar 31, 2025 | 197.00 Mn |
| Dec 31, 2024 | 196.00 Mn |
| Dec 31, 2024 | 196.00 Mn |
| Sep 30, 2024 | 128.00 Mn |
| Sep 30, 2024 | 128.00 Mn |
| Jun 30, 2024 | 149.00 Mn |
| Jun 30, 2024 | 149.00 Mn |
| Mar 31, 2024 | 164.00 Mn |
| Mar 31, 2024 | 164.00 Mn |
| Dec 31, 2023 | 766.00 Mn |
| Dec 31, 2023 | 766.00 Mn |